Första AP-fonden’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12M | Sell |
58,800
-16,300
| -22% | -$587K | 0.01% | 522 |
|
|
2025
Q1 | $2.34M | Sell |
75,100
-169,100
| -69% | -$5.26M | 0.02% | 515 |
|
|
2024
Q4 | $6.23M | Buy |
244,200
+1,800
| +0.7% | +$45.9K | 0.04% | 353 |
|
|
2024
Q3 | $6.86M | Buy |
242,400
+6,500
| +3% | +$184K | 0.05% | 334 |
|
|
2024
Q2 | $6.22M | Buy |
235,900
+137,100
| +139% | +$3.62M | 0.06% | 311 |
|
|
2024
Q1 | $3M | Buy |
98,800
+29,700
| +43% | +$902K | 0.03% | 496 |
|
|
2023
Q4 | $1.94M | Buy |
+69,100
| New | +$1.94M | 0.02% | 542 |
|
|
2023
Q3 | – | Sell |
-71,900
| Closed | -$2.21M | – | 563 |
|
|
2023
Q2 | $2.21M | Buy |
+71,900
| New | +$2.21M | 0.02% | 512 |
|
|
2022
Q4 | – | Sell |
-51,500
| Closed | -$2.07M | – | 572 |
|
|
2022
Q3 | $2.07M | Buy |
+51,500
| New | +$2.07M | 0.03% | 508 |
|